Concordia International (CXRX) Reports Q2 Loss of $3.51/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Concordia International Corp. Announces Second Quarter 2018 Results
August 8, 2018 7:00 AM EDT- Also Announces Executive Leadership Transition -
Second quarter 2018 revenue of approximately $139 million Second quarter 2018 GAAP net loss of $180 million Second quarter 2018 Adjusted EBITDA1 of approximately $67 million Generated cash flow from operations of approximately $84 million in the first six months of 2018 and concluded the second quarter of 2018 with a cash balance of $306 million, which includes $46 million of restricted cashMISSISSAUGA, ON, Aug. 8, 2018 /PRNewswire/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharmaceutical company... More
